Slide Presentation from the AHRQ 2007 Annual Conference

Conclusion

Metoclopramide confers an increased risk for the initiation of treatment generally reserved for the management of idiopathic Parkinson's disease.

Notes:

In summary, we found that metoclopramide use confers an increased risk for the initiation of a treatment generally reserved for the management of idiopathic Parkinson's Disease. Such polypharmacy may represent the misdiagnosis of Parkinson's Disease in older patients suffering drug-induced parkinsonian symptoms.